These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20167996)

  • 1. Endothelial function is impaired in HIV-infected patients with lipodystrophy.
    Masiá M; Padilla S; García N; Jarrin I; Bernal E; López N; Hernández I; Gutiérrez F
    Antivir Ther; 2010; 15(1):101-10. PubMed ID: 20167996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
    He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
    Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy.
    Kovacic JC; Martin A; Carey D; Wand H; Mallon PW; Feneley MP; Emery S; Cooper DA; Carr A;
    Antivir Ther; 2005; 10(1):135-43. PubMed ID: 15751771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function.
    Kathiresan S; Gona P; Larson MG; Vita JA; Mitchell GF; Tofler GH; Levy D; Newton-Cheh C; Wang TJ; Benjamin EJ; Vasan RS
    Circulation; 2006 Feb; 113(7):938-45. PubMed ID: 16476848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus.
    Somers EC; Marder W; Kaplan MJ; Brook RD; McCune WJ
    Ann N Y Acad Sci; 2005 Jun; 1051():271-80. PubMed ID: 16126968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
    Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
    Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
    Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
    Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial function is impaired in patients with primary antiphospholipid syndrome.
    Stalc M; Poredos P; Peternel P; Tomsic M; Sebestjen M; Kveder T
    Thromb Res; 2006; 118(4):455-61. PubMed ID: 16274735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease.
    Guaraldi G; Ventura P; Garlassi E; Orlando G; Squillace N; Nardini G; Stentarelli C; Zona S; Marchini S; Moriondo V; Tebas P
    HIV Med; 2009 Jan; 10(1):28-34. PubMed ID: 19125962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index.
    Brevetti G; Silvestro A; Schiano V; Chiariello M
    Circulation; 2003 Oct; 108(17):2093-8. PubMed ID: 14530195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat distribution and endothelial function in normal-overweight menopausal women.
    Marchesi S; Vaudo G; Lupattelli G; Lombardini R; Roscini AR; Brozzetti M; Siepi D; Mannarino E
    J Clin Pharm Ther; 2007 Oct; 32(5):477-82. PubMed ID: 17875114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
    Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
    Yki-Järvinen H; Sutinen J; Silveira A; Korsheninnikova E; Fisher RM; Kannisto K; Ehrenborg E; Eriksson P; Hamsten A
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):688-94. PubMed ID: 12615670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease.
    Brevetti G; Martone VD; de Cristofaro T; Corrado S; Silvestro A; Di Donato AM; Bucur R; Scopacasa F
    Thromb Haemost; 2001 Jan; 85(1):63-6. PubMed ID: 11204590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial function in HIV-infected patients with low or mild cardiovascular risk.
    Blanco JJ; García IS; Cerezo JG; de Rivera JM; Anaya PM; Raya PG; García JG; López JR; Hernández FJ; Rodríguez JJ
    J Antimicrob Chemother; 2006 Jul; 58(1):133-9. PubMed ID: 16702174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.